Topics in Antiviral Medicine^™

Perspective

• Managing Adverse Effects and Complications in Completing Treatment for Hepatitis C Virus Infection
  Kenneth E. Sherman, MD, PhD
• Cardiovascular Risk and Dyslipidemia Management in HIV-Infected Patients
  James H. Stein, MD
• Beyond Telaprevir and Boceprevir: Resistance and New Agents for Hepatitis C Virus Infection
  David L. Wyles, MD

Cases From the Field

• Syphilis Negatively Influences the Response to Hepatitis C Virus Treatment in an HIV-Infected Patient
  Ellen H. Nagami, BA, Arthur Y. Kim, MD, Rachel P. Baden, MD, Barbara H. McGovern, MD